Soleno Therapeutics, Inc. clinical trials
Acquired by Neurocrine Biosciences, May 17, 2026 · source ↗
The registry lists 7 studies whose lead sponsor is Soleno Therapeutics, Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 14, 2026.
Before and after it joined Neurocrine Biosciences
- First submitted before Soleno Therapeutics, Inc. became part of Neurocrine Biosciences
- 7
- First submitted after Soleno Therapeutics, Inc. became part of Neurocrine Biosciences
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Soleno Therapeutics, Inc.7 studies
Something wrong with this grouping? Tell us on the Neurocrine Biosciences page.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. All Neurocrine Biosciences studies →
- Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeEnrolling by invitationNCT07450664
Sponsor listed in the registry: Soleno Therapeutics, Inc. · First submitted before Soleno Therapeutics, Inc. became part of Neurocrine Biosciences
- Open-Label Extension Study of DCCR in Patients With Prader-Willi SyndromeCompletedNCT05701774Phase 3
Sponsor listed in the registry: Soleno Therapeutics, Inc. · First submitted before Soleno Therapeutics, Inc. became part of Neurocrine Biosciences
- An Open-Label Study of Diazoxide Choline in Patients With Genetic ObesitiesWithdrawnNCT05532020Phase 2
Sponsor listed in the registry: Soleno Therapeutics, Inc. · First submitted before Soleno Therapeutics, Inc. became part of Neurocrine Biosciences
- PWS Outcomes Assessment StudyCompletedNCT04102839
Sponsor listed in the registry: Soleno Therapeutics, Inc. · First submitted before Soleno Therapeutics, Inc. became part of Neurocrine Biosciences
- Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal PeriodCompletedNCT03714373Phase 3
Sponsor listed in the registry: Soleno Therapeutics, Inc. · First submitted before Soleno Therapeutics, Inc. became part of Neurocrine Biosciences
- A Study of Diazoxide Choline in Patients With Prader-Willi SyndromeCompletedNCT03440814Phase 3
Sponsor listed in the registry: Soleno Therapeutics, Inc. · First submitted before Soleno Therapeutics, Inc. became part of Neurocrine Biosciences
- An Open-Label Study of DCCR Tablet in Patients With PWSWithdrawnNCT04086810Phase 3
Sponsor listed in the registry: Soleno Therapeutics, Inc. · First submitted before Soleno Therapeutics, Inc. became part of Neurocrine Biosciences